Targeting BCL2 Family in Human Myeloid Dendritic Cells: A Challenge to Cure Diseases with Chronic Inflammations Associated with Bone Loss
Rheumatoid arthritis (RA) and Langerhans cell histiocytosis (LCH) are common and rare diseases, respectively. They associate myeloid cell recruitment and survival in inflammatory conditions with tissue destruction and bone resorption. Manipulating dendritic cell (DC), and, especially, regulating the...
Saved in:
| Main Authors: | Selma Olsson Åkefeldt, Mohamad Bachar Ismail, Hélène Valentin, Maurizio Aricò, Jan-Inge Henter, Christine Delprat |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Clinical and Developmental Immunology |
| Online Access: | http://dx.doi.org/10.1155/2013/701305 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acquired BCL2 variants associated with venetoclax resistance in acute myeloid leukemia
by: Fiona C. Brown, et al.
Published: (2025-01-01) -
Expression of Bcl-2 protein and the amplification of c-myc gene in patients with chronic myeloid leukemia
by: Strnad Milica, et al.
Published: (2006-01-01) -
The Evolving Landscape of Childhood Histiocytosis: A Decade of Discovery and Innovation
by: Maurizio Aricò
Published: (2025-05-01) -
Natriuretic peptides as novel regulators of dendritic cells-mediated inflammation
by: Giorgia Manni, et al.
Published: (2025-07-01) -
20(S)-protopanaxadiol inhibits proliferation and induces apoptosis of acute myeloid leukemia cells via targeting Bcl-XL and MCL-1
by: Meng Xu, et al.
Published: (2025-04-01)